![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.biospectrumasia.com/analysis/25/24499/pharmas-obsession-with-obesity-on-rise-.html
https://www.globenewswire.com/news-release/2024/06/28/2905661/0/en/Zealand-Pharma-completes-registration-of-capital-increase.html
https://www.globenewswire.com/news-release/2024/06/28/2906017/0/en/Zealand-Pharma-major-shareholder-announcement-Van-Herk-Investments.html
https://www.globenewswire.com/news-release/2024/06/28/2906009/0/en/Total-number-of-shares-and-voting-rights-in-Zealand-Pharma-at-June-28-2024.html
https://www.globenewswire.com/news-release/2024/06/27/2904890/0/en/Save-the-date-in-your-event-calendar-Join-and-learn-about-the-new-era-of-cancer-care-at-the-ICPO-Theranostics-Virtual-Summit-Nov-14-15-2024.html
https://www.globenewswire.com/news-release/2024/06/25/2904185/0/en/Zealand-Pharma-announces-completion-of-an-upsized-equity-offering-of-8-35-million-new-ordinary-shares-raising-gross-proceeds-of-USD-1-billion-DKK-7-billion.html
https://www.globenewswire.com/news-release/2024/06/25/2903991/0/en/Zealand-Pharma-launches-equity-offering-of-new-shares-raising-gross-proceeds-of-approximately-USD-900-million-DKK-6-257-billion.html
https://www.globenewswire.com/news-release/2024/06/20/2901879/0/en/Zealand-Pharma-announces-positive-topline-results-from-the-Phase-1b-16-week-multiple-ascending-dose-clinical-trial-with-long-acting-amylin-analog-petrelintide.html
https://www.globenewswire.com/news-release/2024/06/13/2898459/0/en/Zealand-Pharma-Increases-its-Share-Capital-as-a-Consequence-of-Exercise-of-Employee-Warrants.html
https://www.globenewswire.com/news-release/2024/06/07/2895248/0/en/Zealand-Pharma-announces-that-Boehringer-Ingelheim-s-survodutide-demonstrates-breakthrough-improvement-in-liver-fibrosis-with-no-worsening-of-MASH-in-64-5-of-patients-with-F2-and-F.html